Bentley Pharmaceuticals Raises Approximately $2.6 Million From Exercise of Class a Warrants.NORTH HAMPTON North Hampton is the name of several places in the United States:
Bentley Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange : BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol) BNT Boston Naming Test (psychology) BNT Bermuda National Trust BNT Bulgarian National TV BNT Broadband Network Termination BNT Binary File Transfer ), a drug delivery company and international manufacturer, marketer, distributor and developer of pharmaceutical products, announced today the results of the exercise of its Class A warrants, which expired at the close of business on Aug. 16, 1999. The company announced that approximately 858,000 Class A warrants were exercised since June 1, 1999, of approximately 2,110,000 that remained outstanding from the 7 million originally issued on February 14, 1996. The balance of approximately 1,252,000 unexercised warrants have expired. The exercise generated $2,574,000 in cash to the company. The exercise of the Class A warrants resulted in the issuance of 858,000 additional shares of common stock and 858,000 additional Class B warrants, which expire on February 14, 2001. James R. Murphy, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bentley Pharmaceuticals, said, "We are very pleased with our warrant holders' response, and we look forward to employing this new capital in the continued growth of our business." Bentley Pharmaceuticals, Inc. is an emerging international pharmaceutical company focused on improving drugs through new drug delivery technologies which it intends to commercialize in the U.S. and other major markets in collaboration with other pharmaceutical companies and on the manufacturing, marketing and distribution of products in Europe, Asia, Northern Africa and Central and South America South America, fourth largest continent (1991 est. pop. 299,150,000), c.6,880,000 sq mi (17,819,000 sq km), the southern of the two continents of the Western Hemisphere. for the treatment of cardiovascular, gastrointestinal, neurological and infectious diseases infectious diseases: see communicable diseases. . Copies of the company's press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, the ability to find effective market distribution channels, development of new products, regulatory approval processes, the impact of competitive products or pricing, unpredictability of patent protection, technological changes, the effect of economic conditions and other uncertainties detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion